Upgrades
- Umicore (UMICY) upgraded by Goldman Sachs from Neutral to Buy
- QuantaSing (QSG) upgraded by Citi from Neutral to Buy
- Aberdeen (SLFPF) upgraded by JPMorgan from Neutral to Overweight
- Holcim (HCMLY) upgraded by Barclays from Underweight to Overweight
- BE Semiconductor (BESIY) upgraded by Kepler Cheuvreux from Hold to Buy
- ArcBest (ARCB) upgraded by BofA from Underperform to Neutral
- Macerich (MAC) upgraded by Mizuho from Neutral to Outperform
- Yum! Brands (YUM) upgraded by Redburn Atlantic from Neutral to Buy
- Atlantic Union (AUB) upgraded by Raymond James from Outperform to Strong Buy
- BAE Systems (BAESY) upgraded by BofA from Underperform to Buy
- Kongsberg Gruppen (NSKFF) upgraded by BofA from Underperform to Buy
- Eagle Bancorp (EGBN) upgraded by Janney Montgomery Scott from Neutral to Buy
Investors Can't Afford to Miss This [sponsor]
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
Downgrades
- Elevation Oncology (ELEV) downgraded by TD Cowen from Buy to Hold
- Marlowe (MRLWF) downgraded by RBC Capital from Outperform to Sector Perform
- Keros Therapeutics (KROS) downgraded by BofA from Buy to Neutral
- Informa TechTarget (TTGT) downgraded by JPMorgan from Neutral to Underweight
- Arch Capital (ACGL) downgraded by Jefferies from Buy to Hold
- Safran (SAFRY) downgraded by Citi from Buy to Neutral
- Telia (TLSNF) downgraded by Redburn Atlantic from Buy to Neutral
- McDonald’s (MCD) downgraded by Redburn Atlantic from Buy to Sell
- Saab (SAABF) downgraded by SEB Equities from Buy to Hold
- Saab (SAABF) downgraded by BofA from Neutral to Underperform
- Renk Group (RNKGF) downgraded by BofA from Buy to Underperform
- Elevation Oncology (ELEV) downgraded by H.C. Wainwright from Buy to Neutral
MAG-7 Stocks Are Dead—Here's What Killed Them [sponsor]
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.